View Item 

Show simple item record

Pachyonychia congenita cornered: report on the 11th A nnual I nternational P achyonychia C ongenita C onsortium Meeting
dc.contributor.authorO'Toole, E.A.en_US
dc.contributor.authorKaspar, R.L.en_US
dc.contributor.authorSprecher, E.en_US
dc.contributor.authorSchwartz, M.E.en_US
dc.contributor.authorRittié, L.en_US
dc.date.accessioned2014-12-09T16:54:07Z
dc.date.availableWITHHELD_12_MONTHSen_US
dc.date.available2014-12-09T16:54:07Z
dc.date.issued2014-11en_US
dc.identifier.citationO'Toole, E.A.; Kaspar, R.L.; Sprecher, E.; Schwartz, M.E.; Rittié, L. (2014). "Pachyonychia congenita cornered: report on the 11th A nnual I nternational P achyonychia C ongenita C onsortium Meeting." British Journal of Dermatology 171(5): 974-977.en_US
dc.identifier.issn0007-0963en_US
dc.identifier.issn1365-2133en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109650
dc.publisherWiley Periodicals, Inc.en_US
dc.titlePachyonychia congenita cornered: report on the 11th A nnual I nternational P achyonychia C ongenita C onsortium Meetingen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109650/1/bjd13341.pdf
dc.identifier.doi10.1111/bjd.13341en_US
dc.identifier.sourceBritish Journal of Dermatologyen_US
dc.identifier.citedreferenceSchwartz ME, Hansen CD, Paller AS et al. Pachyonychia congenita overview. Dermatologist 2014; 22: 36 – 8.en_US
dc.identifier.citedreferenceMcLean WH, Hansen CD, Eliason MJ, Smith FJ. The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 2011; 131: 1015 – 17.en_US
dc.identifier.citedreferenceLeachman SA, Hickerson RP, Schwartz ME et al. First‐in‐human mutation‐targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 2010; 18: 442 – 6.en_US
dc.identifier.citedreferenceHickerson RP, Leake D, Pho LN et al. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. J Dermatol Sci 2009; 56: 82 – 8.en_US
dc.identifier.citedreferenceGoldberg I, Fruchter D, Meilick A et al. Best treatment practices for pachyonychia congenita. J Eur Acad Dermatol Venereol 2014; 28: 279 – 85.en_US
dc.identifier.citedreferenceChen J, Jaeger K, Den Z et al. Mice expressing a mutant Krt75 (K6hf) allele develop hair and nail defects resembling pachyonychia congenita. J Invest Dermatol 2008; 128: 270 – 9.en_US
dc.identifier.citedreferenceRice RH, Bradshaw KM, Durbin‐Johnson BP et al. Distinguishing ichthyoses by protein profiling. PLoS One 2013; 8: e75355.en_US
dc.identifier.citedreferenceRittié L, Sachs DL, Orringer JS et al. Eccrine sweat glands are major contributors to reepithelialization of human wounds. Am J Pathol 2013; 182: 163 – 71.en_US
dc.identifier.citedreferenceGoldberg I, Sprecher E, Schwartz ME, Gaitini D. Comparative study of high‐resolution multifrequency ultrasound of the plantar skin in patients with various types of hereditary palmoplantar keratoderma. Dermatology 2013; 226: 365 – 70.en_US
dc.identifier.citedreferenceGoldberg YP, Cohen CJ, Namdari R et al. Letter to the editor. Pain 2014; 155: 837 – 8.en_US
dc.identifier.citedreferenceGoldberg YP, Price N, Namdari R et al. Treatment of Na v 1.7‐mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain 2012; 153: 80 – 5.en_US
dc.identifier.citedreferenceSamuelov L, Sarig O, Harmon RM et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 2013; 45: 1244 – 8.en_US
dc.identifier.citedreferenceLin Z, Chen Q, Lee M et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet 2012; 90: 558 – 64.en_US
dc.identifier.citedreferenceShen J, van den Bogaard EH, Kouwenhoven EN et al. APR‐246/PRIMA‐1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations. Proc Natl Acad Sci U S A 2013; 110: 2157 – 62.en_US
dc.identifier.citedreferenceHaber RM, Drummond D. Pachyonychia congenita with laryngeal obstruction. Pediatr Dermatol 2011; 28: 429 – 32.en_US
dc.identifier.citedreferencePergolizzi J, Ahlbeck K, Aldington D et al. The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment. Curr Med Res Opin 2013; 29: 1127 – 35.en_US
dc.identifier.citedreferenceAnand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high‐concentration capsaicin 8% patch. Br J Anaesth 2011; 107: 490 – 502.en_US
dc.identifier.citedreferenceWilson NJ, O'Toole E, Milstone LM et al. The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol 2014; 171: 343 – 55.en_US
dc.identifier.citedreferenceEliason MJ, Leachman SA, Feng BJ et al. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 2012; 67: 680 – 6.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bjd13341.pdf
Size:
57.96KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.